Walleye Capital’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Walleye Capital’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-657,385	Closed	-$14M	–	6158
2024 Q1	$14M	Buy	657,385 +406,172	+162%	+$4.86M	0.03%	609
2023 Q4	$2.41M	Buy	+251,213	New	+$1.22M	0.01%	1649

Walleye Capital's FUSN Position: Q2 2024 in Review

Walleye Capital sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 657,385 shares — an estimated $14M sold.

Walleye Capital first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $14M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Walleye Capital reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Walleye Capital sold 657,385 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $14M.
Walleye Capital first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Walleye Capital's Fusion Pharmaceuticals Inc. Common Shares position peaked at $14M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.